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Abstract 
 
Protein interactions with the collagen triple helix play a critical role in collagen fibril 
formation, cell adhesion and signalling. However, structural insight into sequence-
specific collagen recognition is limited to an integrin-peptide complex. A GVMGFO 
motif in fibrillar collagens (O denotes 4-hydroxyproline) binds three unrelated proteins: 
von Willebrand factor (VWF), discoidin domain receptor 2 (DDR2) and the extracellular 
matrix protein SPARC/osteonectin/BM-40. We report the crystal structure at 3.2 Å 
resolution of human SPARC bound to a triple-helical 33-residue peptide harbouring the 
promiscuous GVMGFO motif. SPARC recognises the GVMGFO motifs of the middle 
and trailing collagen chains, burying a total of 720 Å2 of solvent-accessible collagen 
surface. SPARC binding does not distort the canonical triple helix of the collagen 
peptide. In contrast, a critical loop in SPARC is substantially remodelled upon collagen 
binding, creating a deep pocket that accommodates the phenylalanine residue of the 
trailing collagen chain (‘Phe pocket’). This highly restrictive specificity pocket is shared 
with the collagen-binding integrin I-domains, but differs strikingly from the shallow 
collagen-binding grooves of the platelet receptor glycoprotein VI and microbial adhesins. 
We speculate that binding of the GVMGFO motif to VWF and DDR2 also results in 
structural changes and the formation of a ‘Phe pocket’.
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Collagen, the most abundant protein in vertebrates, is characterised by a triple-helical 
structure of three polypeptide chains containing repetitive glycine-X-X’ triplets; the X 
and X’ positions, respectively, are often occupied by the imino acids proline and 4-
hydroxyproline (O). The 28 human collagens have numerous essential functions in tissue 
formation, stability and homeostasis, and mutations in collagen genes cause many human 
diseases (1). Collagens I-III, V and XI form supramolecular fibrils that lend mechanical 
stability to the vertebrate body. Normal collagen fibrillogenesis in vivo requires a number 
of globular proteins interacting with the triple helix, such as small leucine-rich repeat 
proteoglycans (2). Cellular interactions with collagen are mediated by a diverse group of 
transmembrane collagen receptors, including integrins, discoidin domain receptors 
(DDRs) and members of the immunoglobulin superfamily (3-5). While the structure of 
the collagen triple helix has been known for more than 50 years (6), protein-collagen 
interactions remain poorly understood at the atomic level. 
 Synthetic triple-helical peptides have been invaluable in mapping specific binding 
sites within collagen (7). The major integrin-binding site in fibrillar collagens I and II is a 
GFOGER motif (8, 9). The atomic details of this important interaction were revealed by a 
crystal structure of the integrin α2 I-domain bound to a 21-residue triple helical peptide, 
providing the only example to date of a vertebrate protein-collagen complex (10). More 
recent studies have identified a GVMGFO motif, conserved in collagens I-III and situated 
~100 residues (~30 nm) upstream of the GFOGER motif, as a binding hotspot for three 
structurally and functionally distinct proteins: the plasma protein von Willebrand factor 
(VWF), whose interaction with collagen contributes to haemostasis (11); the receptor 
tyrosine kinase DDR2 (12); and the extracellular matrix protein SPARC (13). 
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 SPARC (also called osteonectin or BM-40) is a small evolutionarily conserved 
glycoprotein that modulates cell-matrix interactions and collagen assembly (14, 15). 
SPARC is essential for embryo development in invertebrates (16, 17) and has been 
suggested to act as a chaperone for basement membrane collagen IV (17). Mice lacking 
SPARC develop early-onset cataract, lax skin and bone loss; these phenotype are likely to 
result, at least in part, from perturbed collagen fibrillogenesis or cell adhesion (14, 15). 
Human SPARC consists of an acidic 52-residue segment followed by a follistatin-like 
(FS) domain and an α-helical domain (EC) containing two unusual calcium-binding EF-
hands and the collagen-binding site (18-20). Tissue-derived SPARC is processed by 
proteolytic cleavage in the EC domain, resulting in a ~10-fold increase in collagen 
affinity. This effect can be mimicked by recombinant deletion of helix C (ΔαC mutant) 
(20). To obtain insight into the molecular mechanism of collagen recognition by SPARC, 
we have determined the crystal structure of a complex between SPARC FS-EC ΔαC and 
a triple-helical collagen peptide containing the GVMGFO motif. 
 
Results and Discussion 
 
Structure of the SPARC-Collagen Complex. SPARC FS-EC ΔαC binds with high 
affinity to residues 564-590 of the human collagen α1(III) chain (corresponding to 397-
423 of the triple-helical domain) (13). A 33-residue peptide containing this collagen III 
region preceded by three GPO repeats forms a stable triple-helix and a 1:1 complex with 
SPARC FS-EC ΔαC (data not shown). We determined the crystal structure of this 
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SPARC-collagen complex at 3.2 Å resolution by a combination of molecular replacement 
and heavy atom phasing (Table S1, Fig. S1). 
 The collagen peptide is a straight triple helix of ~95 Å length (Fig. 1). The three 
collagen chains are coiled around each other with the characteristic one-residue stagger, 
leading to the designation of a leading, middle and trailing chain (10). The triple-helical 
twist does not vary much along the collagen peptide: the GPO-rich N-terminus is close to 
an ideal 75 helical symmetry, whereas the remainder of the helix assumes a twist halfway 
between 75 and 107 symmetry (21, 22). SPARC is bound to the C-terminal half of the 
collagen peptide, burying 720 Å2 of solvent-accessible collagen surface. Residues 21-23 
of the middle chain and residues 17-27 of the trailing chain make contacts closer than 4.0 
Å with SPARC; the leading chain does not contribute to SPARC binding (Fig. 2, Table 
S2). Thus, the SPARC-binding site observed in the complex structure spans four collagen 
triplets, GQOGVMGFOGPK (570-581 of the collagen α1(III) chain). In principle, 
SPARC could equally well bind to the leading and middle collagen chains, whose relative 
disposition is identical to that of the middle and trailing chains. As in the case of the 
integrin-collagen complex (10), the observed mode of binding is likely to be determined 
by crystal packing forces. 
 Only the SPARC EC domain interacts with the collagen peptide, although the FS 
domain comes close (4.5 Å) to V20 of the middle chain (Fig. 2B). The collagen-binding 
site of the SPARC EC domain is composed of the long αA helix and the adjacent αE- αF 
loop (Fig. 1). These two elements form a deep pocket that accommodates F23 of the 
collagen trailing chain (Fig. 2C, Table S2). This ‘Phe pocket’, the most notable feature of 
the SPARC-collagen interface, is delineated by several apolar SPARC residues (F146, 
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M150, W153, L242) and, suprisingly, a salt bridge between R149 and E246. The refined 
side chain conformation of the collagen F23 in the ‘Phe pocket’ is unusual and allows the 
phenyl ring of F23 to approach SPARC residue W153 edge-on, suggestive of a C-H...π 
hydrogen bond (23). A similar interaction may also be formed with the carboxylate group 
of E246. 
 SPARC residues W153 and L242 are also involved in the second major apolar 
SPARC-collagen contact, with M21 of the collagen middle chain (Fig. 2D, Table S2). 
Finally, F23 of the middle chain is situated atop SPARC residue M245 at the apex of the 
αE- αF loop. In addition to these apolar interactions, a total of six direct hydrogen bonds 
are formed between SPARC and the collagen peptide, five with the collagen main chain 
and one with the hydroxyl group of O24 of the middle chain. Notably, all polar residues 
at the rim of the ‘Phe pocket’ (R149, E246, the indole nitrogen of W153) are engaged in 
hydrogen bonding with the collagen peptide (Figs. 2C and 2D). 
 Previous studies have shown that the glycan attached to N99 in the FS domain 
modulates the affinity of SPARC binding to fibrillar collagens I and V (24, 25). In our 
structure, the N-acetylglucosamine moities attached to N99 are at >10 Å distance from 
the collagen peptide (Fig. 1), but the glycan may cause steric hindrance when SPARC 
binds to fibrillar collagens. Recently, an atomic model of the collagen I fibril structure 
has been reported, based on diffraction patterns of fibrils from rat tail tendon (26). 
Inspection of this structure shows that the SPARC-binding site is largely exposed on the 
flat surface of the fibril’s gap zone (not shown). Even so, a certain amount of local 
unfolding (disorder) of the fibril surface would appear to be required for SPARC binding 
to occur. 
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Structural Changes within SPARC. Collagen binding is accompanied by substantial 
structural rearrangements within SPARC. Most notably, the crucial ‘Phe pocket’ is not 
present in free SPARC, but is only formed upon collagen binding by extensive 
remodelling of the αE- αF loop in the EC domain (Fig. 3). In the three different structures 
of the uncomplexed SPARC EC domain (18-20), this loop acts like a flap, with I243 and 
P244 plugging the pocket and burying most of the critical W153 side chain (Fig. 3A). In 
the complex with collagen, the αE helix is extended by two irregular turns (there are 
prolines at positions 237, 241 and 244), thus opening up the pocket and completing its 
rim by forming the R149-E246 salt bridge (Figs. 3B and 3C). 
 The SPARC-collagen crystals grown at pH 5.5 are missing a calcium ion in the 
second EF-hand (Fig. S2), but we are confident that the remodelling of the αE-αF loop is 
a consequence of collagen binding and not of incomplete calcium loading. Crucially, loss 
of one of the two calcium ions does not compromise the native structure of the EF-hand 
pair. The partially and fully calcium-loaded EF-hand structures can be superimposed with 
a root-mean-square deviation of 0.59 Å for 44 Cα atoms, whereas complete removal of 
calcium from SPARC is known to result in large conformational changes and abolish 
collagen binding (27). The integrity of the EF-hand pair in the partially loaded state 
appears to be maintained by hydrogen bonding between the calcium ligands and the 
C256-C272 disulphide bridge at the empty EF-hand. Besides the αE-αF loop, there are 
other differences between free and collagen-bound SPARC, including a reorientation of 
the FS domain and changes in the αA-αB loop (Fig. S2); however, these changes are 
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distant from the SPARC-collagen interface and likely to be the result of crystal packing 
forces. 
 Collagen binding to the integrin I-domain results in a conformational change that 
is linked to integrin signal transduction (10). Whether the structural changes within 
SPARC are functionally important is unknown. Computational docking of collagen triple 
helices is often used in the absence of experimental protein-collagen complex structures 
(11, 28, 29). Our observation that collagen binding causes substantial structural changes 
within SPARC cautions against the uncritical use of such docking procedures. 
 
Agreement with Previous Mutagenesis. We previously showed that SPARC residues 
R149, N156, L242, M245 and E246 are important for binding to fibrillar collagen I and 
basement membrane collagen IV (20). All of these residues are now seen to make 
multiple interactions with the collagen peptide, with the exception of N156 (Figs. 2 and 
3). This agreement is remarkable given the unexpected structural changes within SPARC 
upon collagen binding. The critical role of N156 demonstrated by mutagenesis could be 
explained if this residue were involved in a water-mediated hydrogen bond with collagen 
(water molecules are not resolved in our structure). Indeed, a canonical structural water 
molecule (30) is predicted to be present in an appropriate position on the trailing chain, 
bound between the peptide carbonyl group of G22 and the hydroxyl group of O24. 
Collagen triple helices are highly hydrated (30) and other structural water molecules may 
also contribute to the SPARC-collagen interaction. 
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Collagen Binding by Vertebrate and Invertebrate SPARCs. The collagen-binding 
residues of human SPARC are highly conserved in all vertebrate and invertebrate SPARC 
sequences (Fig. S3 and data not shown), suggesting that all SPARCs bind collagen in a 
similar manner as the human orthologue. Indeed, collagen binding by invertebrate 
SPARCs has been demonstrated by genetic (17) and biochemical (31) experiments. 
Lacking an equivalent of helix αB, invertebrate SPARCs have a much shorter connection 
between helices αA and αD (Fig. S3) and may therefore not be subject to the same 
proteolytic activation mechanism as mammalian SPARCs (20). 
 
Prediction of SPARC-Binding Sites in Collagens I-IV. The detailed collagen sequence 
requirements for SPARC binding have not been probed biochemically (13). From our 
structure, we predict an absolute requirement for phenylalanine at position 23 of the 
trailing chain. The apolar nature of the ‘Phe pocket’ would appear to preclude binding of 
polar side chains, whereas aliphatic side chains would not be able to fully occupy the 
available space. We further predict a preference for apolar side chains at positions 21 and 
23 of the middle chain, as well as at position 20 of the trailing chain. Finally position 24 
of both chains should be hydroxyproline to allow (water-mediated) hydrogen bonding 
interactions with N156 and E246 (Figs. 2C and 2D). 
 We have used these structure-derived rules to predict further SPARC-binding 
sites in the fibrillar collagens I-III and in basement membrane collagen IV. Collagen I is a 
[α1(I)]2α2(I) heterotrimer, and we assumed that the two α1(I) chains are adjacent (i.e. not 
leading and trailing). Collagens II and III are homotrimers. The major SPARC-binding 
site in the fibrillar collagens I-III, GVMGFO, is ~600 residues from the C-terminus of the 
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triple helix (13). The only other plausible site from sequence analysis is a GATGFO 
sequence (GAAGFO in collagen III) halfway between the GVMGFO motif and the C-
terminus. Rotary shadowing electron micrographs indeed show a secondary SPARC-
binding site in this region (13). The six distinct mammalian collagen IV chains assemble 
into three heterotrimers, of which the [α1(IV)]2α2(IV) heterotrimer is the most abundant; 
invertebrates have only one type of collagen IV heterotrimer (1, 32). There is 
experimental evidence that the α2(IV) chain in the human [α1(IV)]2α2(IV) heterotrimer is 
trailing (33). We have identified four putative SPARC-binding sites in the human 
[α1(IV)]2α2(IV) heterotrimer, two of which are almost perfect matches for the structure-
derived consensus (Fig. 4). Rotary shadow electron micrographs indeed show multiple 
SPARC-binding sites along the human collagen IV triple-helix (34), but the data do not 
permit the precise locations to be determined. It would be interesting to approach this 
question using peptide libraries (7), but the synthesis of the required heterotrimeric 
collagen peptides is technically challenging. 
 
Comparison with Other Collagen-Binding Proteins. The GVMGFO motif recognised 
by SPARC bears little similarity to the GFOGER motif recognised by integrins, yet the 
two proteins appear to achieve sequence specificity by similar means. SPARC uses a 
restrictive pocket to bind the phenylalanine side chain of the GVMGFO motif (Figs. 2B 
and 2C). Similarly, the crucial glutamic acid side chain of the integrin-binding GFOGER 
is bound in a deep pocket, co-ordinating the divalent metal ion at the metal ion-dependent 
adhesion site (10). SPARC and the integrin I-domain bury a total of 720 Å2 and 660 Å2 of 
solvent-accessible collagen surface, respectively, with both proteins undergoing structural 
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changes upon collagen binding. One notable difference is that the collagen peptide is 
kinked in the complex with the integrin I-domain, but remains completely straight in the 
complex with SPARC. 
 VWF and DDR2 recognise the same GVMGFO motif as SPARC, and the 
phenylalanine side chain in collagen is critical for all three interactions (11, 12). It is thus 
reasonable to assume that SPARC, VWF and DDR2 share a common mode of collagen 
recognition, in particular with regard to the critical phenylalanine residue. Whether the 
three proteins compete for collagen in a physiological situation remains to be studied. 
 The collagen-binding A3 domain of VWF has been crystallised and its collagen 
binding site mapped by NMR, antibody blocking and mutagenesis experiments (35-38). 
The collagen-binding site delineated by these studies is a shallow groove, with no 
obvious ‘Phe pocket’. We hypothesise that a ‘Phe pocket’ is formed upon collagen 
binding to the VWF A3 domain and that W982, which lies buried beneath the collagen-
binding site, is part of this pocket. In support of this hypothesis, there is evidence for 
conformational variability in this region: the four crystallographically independent 
structures of the A3 domain show substantial differences in the vicinity of W982 (35, 36), 
and fluorescence experiments have shown that W982 exists in multiple rotamers (39). 
 The collagen-binding site of in the discoidin domain of DDR2 also is a shallow 
groove, into which a generic (GPO)n triple helix could be docked (29). How DDR2 
achieves sequence specificity was not revealed by this study, however. A likely candidate 
for binding the phenylalanine side chain of the GVMGFO motif is the surface-exposed 
side chain of W52, whose mutation to alanine abolishes collagen binding (29). Given that 
 12 
the collagen-binding groove of DDR2 is made up of several long loops, pronounced 
structural changes upon collagen binding are to be expected. 
 Platelet glycoprotein VI (GPVI) binds to certain GPO-rich collagen sequences 
(40). Structure determination of the GPVI ectodomain has revealed a shallow groove 
appropriate for binding a (GPO)n triple helix (28), but the structural basis for sequence-
specific collagen binding remains unknown. Finally, a number of microbial collagen 
receptors bind triple-helical collagen without any apparent sequence specificity. The 
structure of Staphylococcus aureus CNA in complex with a (GPO)n collagen peptide has 
revealed a mode of binding termed the ‘collagen hug’ (41). The collagen triple helix is 
clamped by the two CNA domains, one of which accommodates the GPO repeats of the 
peptide in a relatively featureless and mostly hydrophobic groove. 
 In summary, our structure has revealed how the hydrophobic GVMGFO motif in 
fibrillar collagens is recognised by SPARC. An unexpected conformational change in 
SPARC creates a deep specificity pocket that binds the phenylalanine side chain of the 
GVMGFO motif. The same motif is also recognised by VWF and DDR2, and we predict 
that collagen binding to these proteins results in the formation of similar ‘Phe pockets’.
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Methods 
 
Peptide Synthesis, Protein Expression and Complex Formation. The collagen peptide 
was prepared by solid-phase synthesis as described in SI Materials and Methods. SPARC 
FS-EC ΔαC was produced in human embryonic kidney 293 cells as described (20). The 
SPARC-peptide complex was formed by mixing protein and peptide in a ~1:1.5 ratio and 
purified by size exclusion chromatography as described in SI Materials and Methods. 
 
Crystallisation, Data Collection and Structure Determination. The SPARC-collagen 
complex was crystallised as described in SI Materials and Methods. X-ray diffraction 
data were collected and processed as described in SI Materials and Methods. The 
structure of the SPARC complex was solved by a combination of molecular replacement 
and SIRAS techniques, and refined to an R-factor of 0.254 (Rfree = 0.320) at 3.2 Å 
resolution, as described in SI Materials and Methods. Data processing, phasing and 
refinement statistics are listed in Table S1. 
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Figure Legends 
 
Fig. 1. Crystal structure of SPARC FS-EC ΔαC bound to a 33-residue collagen peptide 
(stereo view). The FS and EC domains of SPARC are in green and cyan, respectively. 
Disulphide bridges are in pale pink, the glycan attached to N99 is in grey, and a calcium 
ion is shown as a purple sphere. The collagen peptide is shown as a Cα ribbon (leading 
chain, yellow; middle chain, orange; trailing chain, red). The chain termini, selected 
helices and the location of the αC deletion are labelled. 
 
Fig. 2. Details of the SPARC-collagen interaction. (A) Sequence of the collagen peptide, 
indicating the one-residue stagger between the chains. The sequence numbering of the 
leading strand is indicated at the top, and the SPARC-binding motifs of the middle and 
trailing chains are coloured. (B) Surface representation of the collagen binding site of 
SPARC. The FS and EC domains of SPARC are in green and cyan, respectively. The 
collagen peptide is shown as a Cα ribbon (leading chain, yellow; middle chain, orange; 
trailing chain, red). Selected residues of the middle and trailing chains are shown in 
atomic detail and are labelled. (C) Interactions of SPARC with the trailing chain. SPARC 
is shown as a cartoon with semitransparent surface rendering. Selected SPARC residues 
are shown in atomic detail and are labelled. The collagen leading and middle chains are 
shown as a Cα ribbon and the trailing chain is shown in atomic detail. Hydrogen bonds 
are indicated by dashed lines. (D) Interactions of SPARC with the collagen middle chain. 
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Fig. 3. Structural changes within SPARC upon collagen binding. (A) Surface 
representation of the collagen binding region in apo SPARC. The FS and EC domains are 
in green and cyan, respectively. Residues implicated in collagen binding by mutagenesis 
(20) are in purple and labelled. W153 is shown in blue and the location of P244 (see text) 
is indicated. (B) Surface representation of the collagen-binding site in the SPARC-
collagen complex. The colour scheme is the same as in A. The side chain of F23 of the 
collagen trailing chain is shown in atomic detail (red) to faciliate comparison with Figs. 1 
and 2. (C) Stereo view of a superposition of the region surrounding the ‘Phe pocket’ in 
apo SPARC (light brown) and the SPARC-collagen complex (cyan). Selected residues 
are shown in atomic detail and are labelled. F23 of the collagen trailing chain is shown as 
a semitransparent space-filling model (red). 
 
Fig. 4. Putative SPARC-binding sites in collagen IV. Shown are partial sequences of 
human collagen III (SwissProt entry P02461) and collagen IV (α1 chain, P02462; α2 
chain, P08572). The SPARC-binding site in collagen III is highlighted; residues that are 
predicted to be strictly required for SPARC binding (see text) are in red, residues that 
should be apolar are in orange. The same colouring scheme is used to indicate the four 
putative SPARC-binding sites in collagen IV. 
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Materials and Methods 
 
Peptide synthesis. The collagen peptide (GPO)3GPSGPRGQOGVMGFOGPKGPOGAO 
(O denotes 2R,4R-hydroxyproline) was synthesised with an ABI 433A synthesiser. 
Couplings were carried out on a Fmoc-PAL-PEG-PS resin (0.16 mmol/g) (Applied 
Biosystems). Fmoc-Gly-OH, Fmoc-Pro-OH, Fmoc-Ser(tBu)-OH, Fmoc-Arg(Pbf)-OH, 
Fmoc-Gln(Trt)-OH, Fmoc-Val-OH, Fmoc-Met-OH, Fmoc-Phe-OH, Fmoc-Lys(Boc)-OH 
and Fmoc-Ala-OH were from Applied Biosystems and Fmoc-4(R)Hyp(tBu)-OH was 
from Novabiochem. O-(7-azabenzotriazol-1-yl)-1.1.3.3-tetramethyluronium 
hexafluorophosphate (HATU, 4.0 equivalents; Perseptive Biosystems) and 
diisopropylethylamine were used as the coupling reagent. The peptide was cleaved from 
the resin with Reagent R (trifluoroacetic acid:thioanisole-1,2:ethanedithiol:anisole, 
90:5:3:2) and separated from the cleavage cocktail by precipitation with diethyl ether at 
4 oC. The peptide was dissolved in 0.1% trifluoroacetic acid (TFA) and purified by 
preparative HPLC (Vydac® C18, 5µm, 300Å, 250 x 50 mm, W. R. Grace) using a 0-50% 
acetonitrile gradient in 0.1% TFA for elution. The peptide was characterised by amino 
acid analysis and electrospray/quadrupole/time-of-flight mass spectrometry (Q-tof micro, 
Waters Asociates). The correct amino acid composition was obtained and the mass was 
determined to be 3064.0 Da (calculated 3064.4 Da). 
 
Protein production and complex formation. The human SPARC FS-EC ΔαC protein 
(residues 53-286 of SwissProt entry P09486, with residues 196-203 deleted) was 
expressed in HEK293 cells and purified as described (1). The SPARC-collagen complex 
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was formed by dissolving the lyophilised collagen peptide in a concentrated protein 
solution (molar peptide:protein ratio ~1.5:1) and purified by size exclusion 
chromatography on a 24 ml Superdex 200 column (GE Healthcare) with 0.01 M Na-
HEPES pH 7.5, 0.14 M NaCl, 1 mM CaCl2 as the running buffer. The complex eluted in 
a single sharp peak at 14.8 ml, compared with 15.7 ml for the free protein. 
 
Crystallisation and data collection. The SPARC-collagen complex was concentrated to 
15 mg/ml and crystallised at room temperature by the hanging drop method, using 0.1 M 
bis Tris-HCl pH 5.5, 0.25 M ammonium sulphate, 12-14% (w/v) PEG3350 as the 
precipitant. Large tetragonal bipyramids grew within two days and were flash-frozen in 
liquid nitrogen using 20% glycerol as cryoprotectant. A di-µ-iodo-
bis(ethylenediamine)diplatinum (PIP) derivative was prepared by soaking a crystal in a 
10% saturated PIP solution for 18 hours. Diffraction data were collected at 100 K on 
station 10.1 at the SRS Daresbury and processed with MOSFLM (www.mrc-
lmb.cam.ac.uk/harry/mosflm) and programs of the CCP4 suite (2). Data collection 
statistics are listed in Table S1. 
 
Structure solution and refinement. The SPARC-collagen structure was solved by a 
combination of molecular replacement and single isomorphous replacement with 
anomalous scattering (SIRAS). The SPARC EC ΔαC domain (residues 138-195/204-286) 
(1) could be located with PHASER (3, 4) with a translation function Z-score of 9.9, but 
all attempts to locate the FS domain or the collagen peptide were unsuccessful. Useful 
SIRAS phases were obtained from a poor PIP derivative with AutoSHARP 
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(Globalphasing Ltd, Cambridge, UK). The electron density map after density 
modification confirmed the position of the EC domain and revealed the position of a 
large part (residues 84-137) of the FS domain. Refinement of the incomplete SPARC 
model against the native 1 data with CNS (5) resulted in a R-factor of 0.451 (Rfree 0.497) 
at 3.2 Å resolution and yielded an electron density map that showed strong density for the 
collagen peptide. Distinctive electron density for the amino acid side chains of the 
GVMGFO motif allowed the direction and register of the three collagen chains to be 
determined (Fig. S1). Multiple rounds of rebuilding and refinement with CNS lowered 
the R-factor to 0.284 (Rfree 0.336). A final round of TLS refinement (four TLS bodies) 
with PHENIX (6) resulted in the final R-factor of 0.254 (Rfree 0.320). The final model 
comprises SPARC residues 54-187 and 206-285, two N-acetyl glucosamine moities 
attached to N99, one calcium and one sulphate ion, as well as all 3x33 collagen residues. 
Residual difference electron density in the distal portion of the SPARC FS domain 
indicates that this part of the structure (which is distant from the SPARC-collagen 
interface) suffers from disorder, explaining the relatively high R-factors. Similar disorder 
was encountered in the structure determination of apo SPARC FS-EC (7). Phasing and 
refinement statistics are listed in Table S1. 
 
Figures and analysis. The figures were made with PYMOL (www.pymol.org). 
Accessible surfaces were calculated with the CCP4 program AREAIMOL (2). Collagen 
superhelix parameters were calculated with a CNS script kindly provided by Jordi Bella 
(University of Manchester, UK). 
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Figure Legends 
 
Fig. S1. Stereo view of the electron density for the collagen peptide. Shown is a 3000K 
simulated annealing Fobs-Fcalc omit map contoured at 2.0 σ. Residues 19-27 
(GVMGFOGPK) of all three collagen chains were deleted from the coordinate file prior 
to refinement and map calculation. Superimposed on the map is the final refined collagen 
model (yellow, leading chain; orange, middle chain; red, trailing chain). Selected residues 
are labelled. 
 
Fig. S2. Comparison of apo SPARC and the SPARC-collagen complex. (A). 
Superposition of apo SPARC (light brown) and SPARC in the collagen complex (cyan). 
The two structures were superimposed on 44 Cα atoms of EF-hand pair (r.m.s. deviation 
0.59 Å) and are shown as Cα traces. The first and last residues of the polypeptide chains 
are labelled, as the EF-hands and selected helices. The FS domain (on the left) is 
positioned differently in the two structures, most likely as a result of crystal packing 
forces. (B) Calcium coordination in apo SPARC FS-EC ΔαC (1). Calcium ions are shown 
as pink spheres. Calcium-ligand bonds are indicated by solid black lines. Selected 
residues are shown in atomic detail and are labelled. (C) Calcium coordination in SPARC 
FS-EC ΔαC with bound collagen peptide (this study). Hydrogen bonds at the empty EF-
hand 2 are indicated by dashed black lines. 
 
Fig. S3. Sequence alignment of selected SPARC EC domains. The sequences are of 
human SPARC (SwissProt P09486), human SPARC-like/hevin (Q14515), Xenopus 
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laevis SPARC (P36378), Drosophila melanogaster SPARC (O97365) and 
Caenorhabditis elegans SPARC (P34714). Conserved residues are highlighted in yellow 
and cysteines are in red. Residues involved in calcium and collagen binding to human 
SPARC are indicated by pink circles and black inverted triangles, respectively. The 
sequence numbering and α-helices A-G of human SPARC are indicated above the 
alignment. 
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Table S1. Crystallographic statistics 
 
 Native 1 Native 2 PIP derivative 
Data Collection    
Space group P42212 P42212 P42212 
Unit cell dimensions (Å) a = b = 89.79 
c = 127.10 
a = b = 90.19 
c = 127.12 
a = b = 90.40 
c = 127.69 
Beamline SRS 10.1 SRS 10.1 SRS 10.1 
Wavelength (Å) 0.980 0.980 1.045 
Resolution (Å) 20-3.2 (3.37-3.20)a 20-3.5 (3.69-3.50) 20-3.8 (4.01-3.80) 
Unique reflections 9046 7016 5589 
Multiplicity 8.7 (8.3) 6.2 (6.1) 7.9 (8.2) 
Completeness (%) 99.6 (100) 99.4 (100) 99.3 (100) 
Rmerge 0.085 (0.272) 0.073 (0.220) 0.118 (0.474) 
Heavy Atom Phasing    
Rderiv with native 2   0.203 
Heavy atom sites   1 
Phasing power, acentric   0.71 
Refinement    
Reflections 9019   
Atoms 2300   
Rcryst/Rfree 0.254/0.320   
Rmsd bonds (Å) 0.009   
Rmsd angles (°) 1.4   
Average/Wilson B (Å2) 87.3/74.0   
Ramachandran plot (%)b 70.0/29.1/0.9/0.0   
 
aValues in parantheses refer to the highest resolution shell. 
bPercentage of residues in most favoured, additionally allowed, generously allowed, and disallowed regions 
(8). 
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Table S2. Collagen-SPARC contacts with d ≤ 4 Å 
 
Collagen Atom SPARC Atom Distance (Å) Contact Type 
Leading Chain    
(V20 CG2 F92 CD2 4.51 closest contact with SPARC) 
 
Middle Chain    
M21 SD L242 CD1 3.27 vdWa 
M21 CE W153 CZ2 3.47 vdW 
 W153 CH2 3.65 vdW 
 L242 CD1 3.35 vdW 
F23 CD2 M245 SD 3.75 vdW 
 M245 CE 3.72 vdW 
F23 CE2 M245 CE 3.50 vdW 
O24 OD M245 O 2.68 H-bondb 
 E246 OE2 2.31 H-bond 
    
Trailing Chain    
Q17 OE1 R184 CB 3.96 vdW 
 R184 CG 3.78 vdW 
 R184 CD 3.91 vdW 
O18 O R184 NH1 2.73 H-bond 
G19 O R184 NH2 2.87 H-bond 
V20 CG1 V157 CG2 3.62 vdW 
 T160 OG1 3.93 vdW 
M21 O W153 NE1 2.87 H-bond 
F23 CD1 W153 CG 3.37 vdW 
 W153 CD1 3.79 vdW 
 W153 CD2 3.52 vdW 
F23 CE1 W153 CD2 3.11 C-H...π H-bond?c 
 W153 CE3 3.10 C-H...π H-bond? 
 W153 CE2 3.80 vdW 
 W153 CZ3 3.76 vdW 
F23 CZ M150 CA 3.88 vdW 
 M150 CB 3.77 vdW 
 M150 CG 3.65 vdW 
F23 CD2 R149 NH2 3.68 vdW 
 E246 OE2 3.14 C-H...π H-bond? 
 E246 CD 3.22 C-H...π H-bond? 
 E246 CG 3.68 vdW 
 E246 OE1 3.66 vdW 
F23 CE2 E246 CG 3.75 vdW 
 F146 CE1 3.98 vdW 
 F146 CZ 3.85 vdW 
O24 O R149 NE 3.09 H-bond 
 R149 NH2 3.45 vdW 
O24 OD D152 CB 3.84 vdW 
 D156 ND2 3.79 water-mediated H-bond? 
K27 N E145 OE2 2.87 H-bond 
 
avan der Waals contact 
bpolar hydrogen bond 
chydrogen bond between C-H donor and π-electron acceptor (9) 
 
 







